Related Experiment Videos
The effect of trisomy 21 on the patterns of polypeptide synthesis in human fibroblasts
Abstract:
In addition to direct gene dosage effects, the deleterious phenotypic consequences of aneuploidy may result from secondary regulatory effects on the production and degradation of gene products coded for by other chromosomes. In an initial test of the hypothesis that extensive secondary effects play an important role in the phenotypic consequences of aneuploidy, we have used two-dimensional gel electrophoresis with radioautography to look for such secondary effects among the polypeptides synthesized by human fibroblasts grown in vitro. The polypeptide patterns of fibroblast strains from four trisomy 21 subjects and one trisomy 21/normal mosaic were compared to those from five matched normal subjects. Of approximately 850 polypeptides visualized, only four show a pattern of variation which may be related to trisomy 21. Additional differences in polypeptide concentrations were found among the strains, attributable to genetic heterogeneity between donor individuals and differences in tissue of origin. These results indicate that, at least in fibroblasts in vitro, trisomy 21 does not cause major regulatory changes in the rates of production and degradation of a large number of polypeptides.
Insights
Aneuploidy, such as trisomy 21 (Down syndrome), may cause harm through secondary regulatory effects. This study found minimal evidence of such widespread effects on protein production in human fibroblasts.
Area of Science:
- Genetics and Molecular Biology
- Cell Biology
- Human Disease Research
Background:
- Aneuploidy, an abnormal chromosome number, can lead to detrimental health effects beyond direct gene dosage.
- Secondary regulatory effects on gene product synthesis and degradation are hypothesized to contribute to aneuploidy's phenotypic consequences.
Purpose of the Study:
- To investigate the extent of secondary regulatory effects on polypeptide production in aneuploid human cells.
- To test the hypothesis that widespread secondary effects play a significant role in the phenotypic outcomes of aneuploidy.
Main Methods:
- Utilized two-dimensional gel electrophoresis and radioautography to analyze polypeptide synthesis in human fibroblasts.
- Compared protein profiles from fibroblast strains of individuals with trisomy 21 and matched normal controls.
Main Results:
- Out of approximately 850 visualized polypeptides, only four exhibited variations potentially linked to trisomy 21.
- Observed differences in polypeptide concentrations were largely attributed to individual genetic variation and tissue origin, not aneuploidy.
- These findings suggest trisomy 21 does not induce substantial regulatory changes in a broad range of polypeptides in vitro.
Conclusions:
- In vitro human fibroblasts from trisomy 21 subjects show minimal evidence of major secondary regulatory effects on protein synthesis.
- The study indicates that widespread regulatory disruptions are unlikely to be the primary driver of phenotypic consequences in aneuploidy, at least in this cellular context.